Wall Street Zen cut shares of SANUWAVE Health (NASDAQ:SNWV - Free Report) from a buy rating to a hold rating in a research report released on Saturday morning.
SANUWAVE Health Stock Performance
Shares of SANUWAVE Health stock traded up $0.56 during trading on Friday, reaching $28.18. The company's stock had a trading volume of 49,180 shares, compared to its average volume of 31,968. The stock has a market capitalization of $241.11 million, a P/E ratio of -6.18 and a beta of 1.25. SANUWAVE Health has a 1-year low of $5.17 and a 1-year high of $39.50. The company has a 50-day moving average price of $30.79.
SANUWAVE Health (NASDAQ:SNWV - Get Free Report) last posted its quarterly earnings data on Friday, May 9th. The company reported ($0.66) earnings per share for the quarter. The firm had revenue of $9.34 million during the quarter.
Insiders Place Their Bets
In other SANUWAVE Health news, insider Iulian Cioanta sold 3,639 shares of SANUWAVE Health stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $31.60, for a total transaction of $114,992.40. Following the completion of the sale, the insider now owns 41 shares of the company's stock, valued at approximately $1,295.60. The trade was a 98.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 36.60% of the stock is currently owned by insiders.
Institutional Trading of SANUWAVE Health
A number of institutional investors and hedge funds have recently added to or reduced their stakes in SNWV. Strategic Investment Solutions Inc. IL acquired a new stake in SANUWAVE Health during the 1st quarter worth about $47,000. Goldman Sachs Group Inc. acquired a new stake in SANUWAVE Health during the 1st quarter worth about $337,000. AWM Investment Company Inc. acquired a new stake in SANUWAVE Health during the 1st quarter worth about $18,153,000. Finally, Solas Capital Management LLC acquired a new stake in SANUWAVE Health during the 1st quarter worth about $20,658,000. Institutional investors and hedge funds own 42.53% of the company's stock.
About SANUWAVE Health
(
Get Free Report)
SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.
See Also
Before you consider SANUWAVE Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SANUWAVE Health wasn't on the list.
While SANUWAVE Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
